Thyroid and breast cancer are the most common cancers among young women, which are either synchronous or metachronous, but the association is yet to be elucidated. With the improvement of diagnosis and treatment, there is an increase in breast and thyroid cancer survivors. Hence, attention is shifting towards survivorship. Here, we report the case of a young lady diagnosed with synchronous thyroid and breast cancer who unexpectedly became pregnant during tamoxifen treatment. After a multidisciplinary discussion, endocrine therapy was interrupted and she delivered a healthy baby at term. In conclusion, oncologists should be aware of breast and thyroid cancer co-occurrence and examinations should be conducted together in diagnosis and follow-up. Also, pregnancy is feasible and can be considered after synchronous breast and thyroid cancer diagnosis. Physicians need to emphasise the use of barrier contraceptives to patients undergoing endocrine therapy. However, the optimum timing for pregnancy after breast cancer and the safety of endocrine therapy interruption in hormonal-positive patients should be discussed and managed by a multidisciplinary team.
Breast Cancer Res. 2014 Aug 27;16(4):427
[PMID:
25436920]
Eur J Cancer. 2011 Jan;47(1):74-83
[PMID:
20943370]
Clin Obstet Gynecol. 2016 Dec;59(4):651-672
[PMID:
27681694]
Cancer Res. 2008 May 15;68(10):3743-51
[PMID:
18483257]
J Obstet Gynaecol Res. 2019 Jul;45(7):1352-1362
[PMID:
31099163]
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):643-649
[PMID:
30541751]
Med Oncol. 2014 Jul;31(7):30
[PMID:
24908061]
Nat Rev Endocrinol. 2016 Nov;12(11):646-653
[PMID:
27418023]
South Asian J Cancer. 2016 Oct-Dec;5(4):209-210
[PMID:
28032092]
NCHS Data Brief. 2009 Aug;(21):1-8
[PMID:
19674536]
Oncologist. 2011;16(11):1547-51
[PMID:
22020212]
Br J Cancer. 2000 May;82(10):1629-35
[PMID:
10817496]
Front Genet. 2013 Dec 05;4:271
[PMID:
24367375]
Eur J Breast Health. 2018 Apr 01;14(2):80-84
[PMID:
29774315]
J Thyroid Res. 2020 May 5;2020:6935724
[PMID:
32426104]
Front Endocrinol (Lausanne). 2017 May 23;8:111
[PMID:
28588554]
Ann Oncol. 2020 Mar 19;:
[PMID:
32199930]
J Med Genet. 2000 Nov;37(11):828-30
[PMID:
11073535]
Ann Oncol. 2013 Oct;24 Suppl 6:vi160-70
[PMID:
23813932]
NCHS Data Brief. 2016 Jan;(232):1-8
[PMID:
26828319]
Int J Cancer. 2015 May 1;136(9):2187-95
[PMID:
25284703]
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):231-8
[PMID:
26908594]
Thyroid. 2004;14 Suppl 1:S27-34
[PMID:
15142374]
World J Surg Oncol. 2018 Jul 5;16(1):130
[PMID:
29976206]
Medicine (Baltimore). 2017 Feb;96(7):e6114
[PMID:
28207532]
Breast. 2015 Jun;24(3):201-7
[PMID:
25662412]
Br J Cancer. 1966 Dec;20(4):670-5
[PMID:
5964601]
J Clin Oncol. 2013 Jan 1;31(1):73-9
[PMID:
23169515]
Hum Mol Genet. 2012 Jan 15;21(2):300-10
[PMID:
21979946]
Cancer Med. 2018 Dec;7(12):6393-6400
[PMID:
30480382]
CA Cancer J Clin. 2018 Nov;68(6):394-424
[PMID:
30207593]
J Med Genet. 2002 Apr;39(4):225-42
[PMID:
11950848]
PLoS One. 2019 Oct 23;14(10):e0221093
[PMID:
31644578]
BMC Public Health. 2019 Nov 29;19(1):1592
[PMID:
31783815]
Breast Care (Basel). 2020 Apr;15(2):148-156
[PMID:
32398983]
Int J Med Sci. 2019 Feb 28;16(3):450-460
[PMID:
30911279]
